Literature DB >> 6324349

Antigens on HTLV-infected cells recognized by leukemia and AIDS sera are related to HTLV viral glycoprotein.

J Schüpbach, M G Sarngadharan, R C Gallo.   

Abstract

Cross-reactive antigens of molecular size of 61,000 to 68,000 daltons are found on the surface of human cells infected by human T-cell leukemia-lymphoma virus (HTLV). They are recognized by antibodies from patients with adult T-cell leukemias and lymphomas, from healthy carriers of HTLV, and from patients with the acquired immunodeficiency syndrome (AIDS). The latter finding has been one of the major reasons for suggesting an association of HTLV with AIDS. However, whether these antigens are of cellular or viral origin has not been clear. These antigens have now been shown to be associated with the presence of viral proteins in the cells, and a cross-reactive glycoprotein of molecular size of 46,000 daltons has been found to be a consistent structural part of viruses purified from several HTLV-producer cell lines. The findings thus suggest a viral (HTLV) origin of these antigens.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6324349     DOI: 10.1126/science.6324349

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  16 in total

1.  HTLV-I antibody studies in villagers in East Sepik Province, Papua New Guinea.

Authors:  R C Sanders; A Levin; G Anian; I Webber; H Lee; P Swanson; A Diwan; R Desowitz; W A Blattner; M P Alpers
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

2.  Human immunodeficiency virus and related retroviruses.

Authors:  R Nájera; M I Herrera; R de Andrés
Journal:  West J Med       Date:  1987-12

3.  Genomic diversity of the acquired immune deficiency syndrome virus HTLV-III: different viruses exhibit greatest divergence in their envelope genes.

Authors:  B H Hahn; M A Gonda; G M Shaw; M Popovic; J A Hoxie; R C Gallo; F Wong-Staal
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

4.  Human monoclonal antibody directed against an envelope glycoprotein of human T-cell leukemia virus type I.

Authors:  S Matsushita; M Robert-Guroff; J Trepel; J Cossman; H Mitsuya; S Broder
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

5.  A monoclonal antibody specific for a 52,000-molecular-weight human T-cell leukemia virus-associated glycoprotein expressed by infected cells.

Authors:  M Robert-Guroff; E Shepard
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

6.  Quantitative estimation by a standardized enzyme-linked immunosorbent assay of human T-cell lymphotropic virus type I antibodies in adult T-cell leukemia and acquired immune deficiency syndrome.

Authors:  S P Halbert; B Poiesz; A E Friedman-Kien; R Montagna; W A Blattner; M Anken
Journal:  J Clin Microbiol       Date:  1986-02       Impact factor: 5.948

7.  Characterization of antibodies reacting with HIV gag proteins occasionally found in the serum of non-infected subjects.

Authors:  P Bürgisser; P C Frei
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

8.  Type 1 human T-cell leukemia virus small envelope protein expressed in mouse cells by using a bovine papilloma virus-derived shuttle vector.

Authors:  M Eiden; M Newman; A G Fisher; D L Mann; P M Howley; M S Reitz
Journal:  Mol Cell Biol       Date:  1985-11       Impact factor: 4.272

9.  Studies of human retroviruses in relation to adult T-cell leukaemia, acquired immune deficiency syndrome, and multiple sclerosis.

Authors:  A Karpas; K Malik; J Lida
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

10.  trans-Activation of the human T-cell leukemia virus long terminal repeat correlates with expression of the x-lor protein.

Authors:  J G Sodroski; W C Goh; C A Rosen; S Z Salahuddin; A Aldovini; G Franchini; F Wong-Staal; R C Gallo; K Sugamura; Y Hinuma
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.